Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manabu Itoh

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Nature Communications|May 23, 2019
Development of an immunodeficient pig model allowing long-term accommodation of artificial human vascular tubesManabu Itoh, Yosuke Mukae, Takahiro Kitsuka, et al.
Scientific Reports|June 29, 2026
Elimusertib exhibits strong synergy with olaparib in ovarian cancer organoids through replication fork interferenceMio Takahashi, Aki Ookubo, Takuma Yoshimura, et al.
Cancer Research Communications|June 3, 2025
High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic TargetTakuma Yoshimura, Takashi Kamatani, Aki Ookubo, et al.
Plos One|February 8, 2018
Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironmentTakanori Eguchi, Chiharu Sogawa, Yuka Okusha, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Nature Communications|May 23, 2019
Development of an immunodeficient pig model allowing long-term accommodation of artificial human vascular tubesManabu Itoh, Yosuke Mukae, Takahiro Kitsuka, et al.
Scientific Reports|June 29, 2026
Elimusertib exhibits strong synergy with olaparib in ovarian cancer organoids through replication fork interferenceMio Takahashi, Aki Ookubo, Takuma Yoshimura, et al.
Cancer Research Communications|June 3, 2025
High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic TargetTakuma Yoshimura, Takashi Kamatani, Aki Ookubo, et al.
Plos One|February 8, 2018
Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironmentTakanori Eguchi, Chiharu Sogawa, Yuka Okusha, et al.
Pageof 9